Format

Send to

Choose Destination
J Am Heart Assoc. 2014 Dec 4;3(6):e001330. doi: 10.1161/JAHA.113.001330.

Comparative effectiveness review of antiplatelet agents in peripheral artery disease.

Author information

1
Department of Community and Family Medicine, Duke University School of Medicine, Durham, NC (K.S.) Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (K.S., R.J.D., S.J., M.R.P.).
2
Division of General Internal Medicine, Duke University Medical Center, Durham, NC (R.J.D.) Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (K.S., R.J.D., S.J., M.R.P.) Duke Evidence-based Practice Center, Duke Clinical Research Institute, Duke University, Durham, NC (R.J.D., B.H.).
3
Division of Cardiology, Duke University Medical Center, Durham, NC (S.J., S.V., S.S., M.R.P.) Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (K.S., R.J.D., S.J., M.R.P.).
4
Division of Cardiology, Duke University Medical Center, Durham, NC (S.J., S.V., S.S., M.R.P.).
5
Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC (V.H.).
6
Duke Evidence-based Practice Center, Duke Clinical Research Institute, Duke University, Durham, NC (R.J.D., B.H.).

KEYWORDS:

antiplatelet therapy; aspirin; clopidogrel; peripheral artery disease

PMID:
25477329
PMCID:
PMC4338727
DOI:
10.1161/JAHA.113.001330
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center